Dr. Symmans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
NYU Grossman School of MedicineResidency, Immunopathology, 1993 - 1995
University of Texas M D Anderson Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
University of Auckland Faculty of Medicine and Health SciencesClass of 1986
Certifications & Licensure
TX State Medical License 2000 - 2025
NY State Medical License 1996 - 2003
PA State Medical License 1992 - 1996- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 1059 citationsMeasurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant ChemotherapyW. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry Mark Kuerer
Journal of Clinical Oncology. 2007-10-01 - 176 citationsStandardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer : recommendations from an international working...Elena Provenzano, Veerle Bossuyt, Giuseppe Viale, David Cameron, Sunil V. Badve
Modern Pathology. 2015-07-24 - 480 citationsMetformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.Jong Ho Cha, Wen Hao Yang, Weiya Xia, Yongkun Wei, Li Chuan Chan
Molecular Cell. 2018-08-16
Press Mentions
Residual Cancer Burden Predicts Outcomes for All Breast Cancer TypesFebruary 25th, 2020
Committees
- Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
